News Medicare to fund Abbott's needle-free diabetes monitor Abbott's new glucose monitoring device could be used by millions of diabetes patients in the US after government-funded health schemes agreed to pay for it.
News Abbott earns CE mark for smartphone-enabled cardiac monitor Confirm Rx Insertable Cardiac Monitor transmits data to smartphone app.
News Abbott’s Zika blood test approved for emergency use Abbott's test is now the first to receive FDA commercial authorisation in an emergency use setting.
News Abbott builds on needle-free diabetes testing with data shar... Abbott's new smartphone app builds on 'revolutionary' needle-free meter
News Abbott unveils next gen point of care diagnostics Abbott hopes for launch of its Alinity suite later this year.
News Abbott’s needleless diabetes platform as effective as self-m... Study demonstrates a 38% reduction in time spent in hypoglycaemia, compared to traditional self monitoring.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.